Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 969-969
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 100
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 18, pp. 6721-6721
Open Access | Times Cited: 41
Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, et al.
Biology (2024) Vol. 13, Iss. 7, pp. 519-519
Open Access | Times Cited: 21
Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows
Christina Antza, Antonio Gallo, Chrysoula Boutari, et al.
Atherosclerosis (2023) Vol. 384, pp. 117272-117272
Open Access | Times Cited: 19
Magnitude and time course of insulin resistance accumulation with the risk of cardiovascular disease: an 11-years cohort study
Xue Tian, Shuohua Chen, Qin Xu, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Omics biomarkers and an approach for their practical implementation to delineate health status for personalized nutrition strategies
Jaap Keijer, Xavier Escoté, Sebastià Galmés, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 23, pp. 8279-8307
Open Access | Times Cited: 14
Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3537-3537
Open Access | Times Cited: 5
The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease Risk
Niekbachsh Mohammadnia, Amber van Broekhoven, Willem A. Bax, et al.
European Journal of Preventive Cardiology (2024)
Closed Access | Times Cited: 5
The Triad of Risk: Linking MASLD, Cardiovascular Disease and Type 2 Diabetes; From Pathophysiology to Treatment
Eleni Michalopoulou, J Thymis, Stamatios Lampsas, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 428-428
Open Access
Genética de la Lp(a) y asociación con el riesgo cardiovascular
Carlos Fernando Yauli Flores, A. Cabrera
Bionatura journal : (2025) Vol. 2, Iss. 1, pp. 1-21
Closed Access
The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease
Qianhui Li, Shuailei Xu, Junxian Shen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Statins—Their Effect on Lipoprotein(a) Levels
Marcin Mateusz Granat
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 1
Open Access
Recommendations For Nutritional Correction in The Treatment of Atherosclerosis
Р. Н. Мустафин, E. A. Galieva
The Russian Archives of Internal Medicine (2025) Vol. 15, Iss. 1, pp. 5-16
Open Access
Causal effects of circulating immune cells on coronary atherosclerosis: Evidence from Mendelian randomization
Xinyu Yang, Yunfeng Yu, Gang Hu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41361-e41361
Open Access
Lipoprotein (a) in the context of atherosclerosis: pathological implications and therapeutic perspectives in myocardial infarction. A narrative review
Ionuţ Cezar Buciu, Eugen Țieranu, Andreea Ştefania Pîrcălabu, et al.
Romanian Journal of Morphology and Embryology (2025) Vol. 65, Iss. 4, pp. 609-616
Open Access
Emerging biomarkers in type 2 diabetes mellitus
Rashid Mir, Mushabab Alghamdi, Waad Fuad BinAfif, et al.
Advances in clinical chemistry (2025)
Closed Access
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 7-16
Open Access
Aspectos fundamentales en la solicitud y determinación de la lipoproteína(a) en el laboratorio clínico
Teresa Arrobas Velilla, Carla Fernández Prendes, Núria Amigó, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2025) Vol. 6, Iss. 1, pp. 17-27
Open Access
Development of a fully automated latex-enhanced immunoturbidimetric method for quantitative serum Lp(a) measurement
Yanyan Liu, Meijiao Li, Hao Zhang, et al.
Biotechnology Letters (2025) Vol. 47, Iss. 2
Closed Access
Evolving concepts of low‐density lipoprotein: From structure to function
Chu‐Huang Chen, Tatsuya Sawamura, Alexander Akhmedov, et al.
European Journal of Clinical Investigation (2025)
Closed Access
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk
Panagiotis Theofilis, Panayotis K. Vlachakis, Paschalis Karakasis, et al.
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Closed Access
Lipoprotein(a) levels and cardiovascular mortality risk in Chinese patients undergoing hemodialysis
Qiaojing Liang, Guojuan Zhang, Liping Jiang, et al.
International Urology and Nephrology (2025)
Closed Access
The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study
Lijun Qiu, Hongwei Qiao
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
Yannis Dimitroglou, Constantina Aggeli, Panagiotis Theofilis, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1669-1669
Open Access | Times Cited: 12
Management of dyslipidemia in coronary artery disease: the present and the future
Kyriakos Dimitriadis, Panagiotis Theofilis, Panagιotis Iliakis, et al.
Coronary Artery Disease (2024) Vol. 35, Iss. 6, pp. 516-524
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top